HMTLF yields 0.83% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, HMTLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HMTLF + PFE for your $10,000?
Hitachi Metals, Ltd. manufacture and sell specialty steel products, functional components and equipment, magnetic materials and applications/power electronics materials, wires and cables, and related products in Japan, North America, Asia, Europe, and internationally. The company's Specialty Steel Products segment offers molds and tool steels, rolls for steel mills, injection molding machine parts, structural ceramic products, and steel-frame joints for construction; automobile-related materials, razor and blade materials, precision cast components, and aircraft- and energy-related materials; and display-related materials, semiconductor and other package materials, and battery-related materials. Its Functional Components and Equipment segment provides HNM ductile cast iron products, cast iron products for transportation equipment, heat-resistant exhaust casting components, and Aluminum components; and piping and infrastructure components. The company's Magnetic Materials and Applications/Power Electronics Materials segment offers rare-earth magnets, ferrite magnets, and other magnets and applied products; and amorphous metals, nanocrystalline magnetic materials, soft ferrite, and applied products, as well as ceramic components. Its Wires, Cables, and Related Products segment provides industrial cables, electronic wires, electric equipment materials, cable assemblies, and industrial rubber products; and automotive electronic components and brake hoses. The company was founded in 1910 and is headquartered in Tokyo, Japan. Hitachi Metals, Ltd. is a subsidiary of Hitachi, Ltd.
Full HMTLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.